BMO Capital Markets assumed coverage on shares of Addus Homecare (NASDAQ:ADUS) in a research note issued to investors on Thursday morning, BenzingaRatingsTable reports. The brokerage issued a market perform rating on the stock.
Other analysts have also issued research reports about the company. ValuEngine lowered Addus Homecare from a strong-buy rating to a buy rating in a report on Thursday, April 4th. Zacks Investment Research lowered Addus Homecare from a buy rating to a hold rating in a report on Tuesday, May 7th. BidaskClub lowered Addus Homecare from a strong-buy rating to a buy rating in a report on Tuesday, June 11th. Finally, Raymond James lifted their target price on Addus Homecare from $75.00 to $81.00 and gave the stock an outperform rating in a report on Thursday, June 13th. One investment analyst has rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average target price of $77.88.
Addus Homecare stock opened at $74.95 on Thursday. The company has a market cap of $988.04 million, a price-to-earnings ratio of 42.58, a price-to-earnings-growth ratio of 2.31 and a beta of -0.09. The business has a fifty day simple moving average of $71.33. Addus Homecare has a 12 month low of $55.25 and a 12 month high of $77.82. The company has a current ratio of 2.87, a quick ratio of 2.87 and a debt-to-equity ratio of 0.10.
In other news, Director Mark L. First sold 440,000 shares of the firm’s stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $74.08, for a total value of $32,595,200.00. Following the transaction, the director now directly owns 19,151 shares in the company, valued at approximately $1,418,706.08. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Brian Poff sold 20,000 shares of the firm’s stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $70.57, for a total value of $1,411,400.00. Following the completion of the transaction, the chief financial officer now owns 38,241 shares in the company, valued at $2,698,667.37. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 460,814 shares of company stock worth $34,061,919. Company insiders own 34.80% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in ADUS. Rhumbline Advisers boosted its stake in shares of Addus Homecare by 243.5% in the 4th quarter. Rhumbline Advisers now owns 28,365 shares of the company’s stock valued at $1,925,000 after purchasing an additional 20,107 shares in the last quarter. SG Americas Securities LLC acquired a new stake in shares of Addus Homecare in the 4th quarter valued at $151,000. State Board of Administration of Florida Retirement System boosted its stake in shares of Addus Homecare by 5.8% in the 4th quarter. State Board of Administration of Florida Retirement System now owns 3,316 shares of the company’s stock valued at $225,000 after purchasing an additional 182 shares in the last quarter. Comerica Bank acquired a new stake in shares of Addus Homecare in the 4th quarter valued at $568,000. Finally, Mackenzie Financial Corp acquired a new stake in shares of Addus Homecare in the 4th quarter valued at $480,000. Hedge funds and other institutional investors own 98.90% of the company’s stock.
Addus Homecare Company Profile
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
Featured Article: What is the Quick Ratio?
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.